Targeting TAMs with anti-MARCO (suppressive TAM marker) antibody converted them to a pro-inflammatory phenotype that favored anti-tumor activity in multiple tumor types[165], adding another entry to the arsenal of therapies against TAMs in restructuring the immune response[166]. The gene discussed is MARCO; the disease is neoplasm.